Search details
1.
More Is Not Better When It Comes to Treating Rectal Cancer With Multimodal Chemoradiation Beyond the Standard Radiation Dose of 5040 cGy.
Dis Colon Rectum
; 65(5): 692-701, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-34082437
2.
Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients.
J Oncol Pharm Pract
; 27(7): 1596-1603, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-33023385
3.
Predictors of adherence to aerobic exercise in rectal cancer patients during and after neoadjuvant chemoradiotherapy.
Psychol Health Med
; 23(2): 224-231, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-28635312
4.
Exercise motivation in rectal cancer patients during and after neoadjuvant chemoradiotherapy.
Support Care Cancer
; 24(7): 2919-26, 2016 07.
Article
in English
| MEDLINE | ID: mdl-26847350
5.
Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.
Invest New Drugs
; 32(5): 1036-45, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24853074
6.
A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.
Radiother Oncol
; 196: 110219, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38479443
7.
Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial.
J Cancer Surviv
; 17(4): 1171-1183, 2023 08.
Article
in English
| MEDLINE | ID: mdl-34841461
8.
Effects of Exercise on Motivational Outcomes in Rectal Cancer Patients During and After Neoadjuvant Chemoradiation: A Phase II Randomized Controlled Trial.
Semin Oncol Nurs
; 39(4): 151419, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37061361
9.
Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
Int J Radiat Oncol Biol Phys
; 117(2): 434-445, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37148982
10.
Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022.
Curr Oncol
; 30(9): 7964-7983, 2023 Aug 29.
Article
in English
| MEDLINE | ID: mdl-37754494
11.
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation.
Am J Clin Oncol
; 45(10): 405-409, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-36106894
12.
Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys
; 113(1): 125-134, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35085715
13.
Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial.
Clin Colorectal Cancer
; 20(3): 216-226, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34158253
14.
Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?
Am J Clin Oncol
; 44(9): 487-494, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-34269694
15.
Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study.
Radiother Oncol
; 154: 93-100, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32941956
16.
Dosimetric Parameters Predicting Late Small Bowel Toxicity in Patients With Rectal Cancer Receiving Neoadjuvant Chemoradiation.
Pract Radiat Oncol
; 11(1): e70-e79, 2021.
Article
in English
| MEDLINE | ID: mdl-32771626
17.
Predictors of adherence to supervised exercise in lymphoma patients participating in a randomized controlled trial.
Ann Behav Med
; 40(1): 30-9, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20563764
18.
Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
Radiother Oncol
; 136: 21-28, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31015125
19.
Peri-anal surface dose in anal canal VMAT radiotherapy.
J Med Imaging Radiat Oncol
; 62(5): 734-738, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-29797501
20.
Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
Trials
; 19(1): 35, 2018 Jan 12.
Article
in English
| MEDLINE | ID: mdl-29329555